HPV-related oropharyngeal cancer: Risk factors for treatment failure in patients managed with primary transoral robotic surgery

John M. Kaczmar, Kay See Tan, Daniel F. Heitjan, Alexander Lin, Peter H. Ahn, Jason G. Newman, Christopher H. Rassekh, Ara A. Chalian, Bert W. O'Malley, Roger B. Cohen, Gregory S. Weinstein

Research output: Contribution to journalArticle

29 Citations (Scopus)

Abstract

Background The purpose of this study was to determine clinical factors that predict locoregional recurrence or distant metastasis in patients with human papillomavirus (HPV)-positive oropharyngeal cancer treated with surgery and guideline-indicated adjuvant therapy. Methods We identified all presumed HPV-positive patients with oropharyngeal cancer in our health system from January 2010 to August 2012 treated with surgery and guideline-indicated adjuvant therapy. Statistical analysis was performed to identify clinical predictors associated with treatment failure. Results One hundred fourteen p16+ oropharyngeal cancers managed with initial surgical resection were identified. Median follow-up was 17 months. Two-year locoregional failure was 3.3% and distant failure was 8.4%. Statistical analysis found that conventional poor prognostic features did not predict treatment failure. Conclusion Locoregional recurrence and development of distant metastatic disease are uncommon in patients who are appropriately selected for surgical management of p16+ oropharyngeal cancer regardless of the presence or absence of conventional poor prognostic features.

Original languageEnglish (US)
Pages (from-to)59-65
Number of pages7
JournalHead and Neck
Volume38
Issue number1
DOIs
StatePublished - Jan 1 2016

Fingerprint

Oropharyngeal Neoplasms
Robotics
Treatment Failure
Guidelines
Recurrence
Neoplasm Metastasis
Health
Therapeutics

Keywords

  • human papillomavirus (HPV)
  • oropharyngeal
  • p16
  • prognostic factors
  • transoral robotic surgery (TORS)

ASJC Scopus subject areas

  • Otorhinolaryngology

Cite this

HPV-related oropharyngeal cancer : Risk factors for treatment failure in patients managed with primary transoral robotic surgery. / Kaczmar, John M.; Tan, Kay See; Heitjan, Daniel F.; Lin, Alexander; Ahn, Peter H.; Newman, Jason G.; Rassekh, Christopher H.; Chalian, Ara A.; O'Malley, Bert W.; Cohen, Roger B.; Weinstein, Gregory S.

In: Head and Neck, Vol. 38, No. 1, 01.01.2016, p. 59-65.

Research output: Contribution to journalArticle

Kaczmar, JM, Tan, KS, Heitjan, DF, Lin, A, Ahn, PH, Newman, JG, Rassekh, CH, Chalian, AA, O'Malley, BW, Cohen, RB & Weinstein, GS 2016, 'HPV-related oropharyngeal cancer: Risk factors for treatment failure in patients managed with primary transoral robotic surgery', Head and Neck, vol. 38, no. 1, pp. 59-65. https://doi.org/10.1002/hed.23850
Kaczmar, John M. ; Tan, Kay See ; Heitjan, Daniel F. ; Lin, Alexander ; Ahn, Peter H. ; Newman, Jason G. ; Rassekh, Christopher H. ; Chalian, Ara A. ; O'Malley, Bert W. ; Cohen, Roger B. ; Weinstein, Gregory S. / HPV-related oropharyngeal cancer : Risk factors for treatment failure in patients managed with primary transoral robotic surgery. In: Head and Neck. 2016 ; Vol. 38, No. 1. pp. 59-65.
@article{9a130db400e84c8d93bd76d68c2347aa,
title = "HPV-related oropharyngeal cancer: Risk factors for treatment failure in patients managed with primary transoral robotic surgery",
abstract = "Background The purpose of this study was to determine clinical factors that predict locoregional recurrence or distant metastasis in patients with human papillomavirus (HPV)-positive oropharyngeal cancer treated with surgery and guideline-indicated adjuvant therapy. Methods We identified all presumed HPV-positive patients with oropharyngeal cancer in our health system from January 2010 to August 2012 treated with surgery and guideline-indicated adjuvant therapy. Statistical analysis was performed to identify clinical predictors associated with treatment failure. Results One hundred fourteen p16+ oropharyngeal cancers managed with initial surgical resection were identified. Median follow-up was 17 months. Two-year locoregional failure was 3.3{\%} and distant failure was 8.4{\%}. Statistical analysis found that conventional poor prognostic features did not predict treatment failure. Conclusion Locoregional recurrence and development of distant metastatic disease are uncommon in patients who are appropriately selected for surgical management of p16+ oropharyngeal cancer regardless of the presence or absence of conventional poor prognostic features.",
keywords = "human papillomavirus (HPV), oropharyngeal, p16, prognostic factors, transoral robotic surgery (TORS)",
author = "Kaczmar, {John M.} and Tan, {Kay See} and Heitjan, {Daniel F.} and Alexander Lin and Ahn, {Peter H.} and Newman, {Jason G.} and Rassekh, {Christopher H.} and Chalian, {Ara A.} and O'Malley, {Bert W.} and Cohen, {Roger B.} and Weinstein, {Gregory S.}",
year = "2016",
month = "1",
day = "1",
doi = "10.1002/hed.23850",
language = "English (US)",
volume = "38",
pages = "59--65",
journal = "Head and Neck",
issn = "1043-3074",
publisher = "Wiley-Liss Inc.",
number = "1",

}

TY - JOUR

T1 - HPV-related oropharyngeal cancer

T2 - Risk factors for treatment failure in patients managed with primary transoral robotic surgery

AU - Kaczmar, John M.

AU - Tan, Kay See

AU - Heitjan, Daniel F.

AU - Lin, Alexander

AU - Ahn, Peter H.

AU - Newman, Jason G.

AU - Rassekh, Christopher H.

AU - Chalian, Ara A.

AU - O'Malley, Bert W.

AU - Cohen, Roger B.

AU - Weinstein, Gregory S.

PY - 2016/1/1

Y1 - 2016/1/1

N2 - Background The purpose of this study was to determine clinical factors that predict locoregional recurrence or distant metastasis in patients with human papillomavirus (HPV)-positive oropharyngeal cancer treated with surgery and guideline-indicated adjuvant therapy. Methods We identified all presumed HPV-positive patients with oropharyngeal cancer in our health system from January 2010 to August 2012 treated with surgery and guideline-indicated adjuvant therapy. Statistical analysis was performed to identify clinical predictors associated with treatment failure. Results One hundred fourteen p16+ oropharyngeal cancers managed with initial surgical resection were identified. Median follow-up was 17 months. Two-year locoregional failure was 3.3% and distant failure was 8.4%. Statistical analysis found that conventional poor prognostic features did not predict treatment failure. Conclusion Locoregional recurrence and development of distant metastatic disease are uncommon in patients who are appropriately selected for surgical management of p16+ oropharyngeal cancer regardless of the presence or absence of conventional poor prognostic features.

AB - Background The purpose of this study was to determine clinical factors that predict locoregional recurrence or distant metastasis in patients with human papillomavirus (HPV)-positive oropharyngeal cancer treated with surgery and guideline-indicated adjuvant therapy. Methods We identified all presumed HPV-positive patients with oropharyngeal cancer in our health system from January 2010 to August 2012 treated with surgery and guideline-indicated adjuvant therapy. Statistical analysis was performed to identify clinical predictors associated with treatment failure. Results One hundred fourteen p16+ oropharyngeal cancers managed with initial surgical resection were identified. Median follow-up was 17 months. Two-year locoregional failure was 3.3% and distant failure was 8.4%. Statistical analysis found that conventional poor prognostic features did not predict treatment failure. Conclusion Locoregional recurrence and development of distant metastatic disease are uncommon in patients who are appropriately selected for surgical management of p16+ oropharyngeal cancer regardless of the presence or absence of conventional poor prognostic features.

KW - human papillomavirus (HPV)

KW - oropharyngeal

KW - p16

KW - prognostic factors

KW - transoral robotic surgery (TORS)

UR - http://www.scopus.com/inward/record.url?scp=84955708255&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84955708255&partnerID=8YFLogxK

U2 - 10.1002/hed.23850

DO - 10.1002/hed.23850

M3 - Article

C2 - 25197014

AN - SCOPUS:84955708255

VL - 38

SP - 59

EP - 65

JO - Head and Neck

JF - Head and Neck

SN - 1043-3074

IS - 1

ER -